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Abstract 
A sensitive and simple HPLC/UV method has been developed and validated for 
the determination of two potential genotoxic impurities, namely methyl 
p-toluenesulfonate (MPTS) and ethyl p-toluenesulfonate (EPTS) at trace levels 
in Pemetrexed sodium API. Applying the concept of threshold of toxicological 
concern (TTC), a limit of 3 ppm each for both genotoxins was calculated based 
on the maximum daily dose of API. A reversed phase LC method using UV 
detection was developed and validated. The method was found to be specific 
and selective for the application. The limit of detection (LOD) and limit of 
quantitation (LOQ) for both MPTS and EPTS was found to be 0.15 ppm (0.009 
µg mL
−1) and 0.5 ppm (0.03 µg mL
−1), respectively, with respect to sample 
concentration. The calibration curves of MPTS and EPTS were linear over the 
concentration range from LOQ to 6 µg/mL. The method was found to be 
specific, precise, linear and accurate and has been successfully applied to 
determine the two genotoxins in commercial batches of the API. 866  A. Nageswari, K. Venkata Siva Rama Krishna Reddy, and K. Mukkanti:   
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Introduction 
p-Toluenesulfonic acid (pTSA) (Figure 1), a strong organic acid, is a common reagent 
used in pharmaceutical industry as an "organic-soluble" acid catalyst or in purification 
steps of chemical synthesis of a drug substance. The applications of p-TSA include but are 
not limited to: Acetalization of an aldehyde [1], Esterification of carboxylic acids [2], and 
Transesterification of an ester [3]. The presence of any residual alcohols like methanol and 
ethanol from synthetic reaction or recrystalization steps may result in the formation of 
corresponding alkyl tosylates, which are known to be Potential Genotoxic Impurities (PGIs) 
[4, 5]. These PGIs, alkyl tosylates due to their DNA alkylation action can induce 
mutagenic, carcinogenic and teratogenic effects [6]. The manufacturing process of the 
subject API involves the solvents methanol and ethanol and p-TSA as a reagent for salt 
formation. Hence there is a highly likelihood for the formation of the two genotoxins, methyl 
p-tolulenesulfonate (Figure 2), and ethyl p-toluenesulfonate (Figure 3) which cannot be 
ignored in the API.  
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Fig. 1.   p-Toluenesulfonic acid 
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Fig. 2.   Formation of methyl p-toluenesulfonate 
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Fig. 3.   Formation of ethyl p-toluenesulfonate 
The assessment and control of Genotoxic impurities (GTIs) in pharmaceutical products 
has received considerable attention in recent years. The International Conference on 
Harmonization (ICH), section Q3A, provides guidance on impurities in New Drug 
Substances [7]. It states that lower reporting thresholds can be appropriate if the impurity 
is unusually toxic. The European Medices Agency (EMEA) issued guidelines for GTI limits   A Sensitive and Simple HPLC-UV Method for Trace Level Quantification of …  867 
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and included the concept of threshold toxicological concern (TTC) to define acceptable risk 
for the new active substances [8]. Recently, in 2008 US FDA (United States Food and 
Drug Administration) has also come up with the draft guidelines on genotoxic and 
carcinogenic impurities in drug substances and drug products [9]. Pharmaceutical 
Genotoxic impurities may potentially increase the risk of cancer in patients.  These 
guidelines describe ways to characterize, monitor and control the level of GTIs in drug 
substances and drug products. A maximum daily exposure target of 1.5 µg per day 
(acceptable Threshold of Toxicological Concern, TTC) is recommended in these 
guidelines [8–10]. 
Based on maximum daily dosage of selected drug substance used in this study, MPTS 
and EPTS are required to be controlled at a combined limit of 0.18 µg/mL in API. 
Due to the increasing concern from the regulatory agencies with respect to potential 
genotoxic impurities, a number of sophisticated analytical techniques,  namely Gas 
chromatographic methods utilizing both FID/MS detectors and HPLC/UPLC coupled with 
UV/MS detectors, are available for the estimation of Genotoxins in drug substances and 
drug products.  
However, some of the analytical methods described in the literature for the determination 
of low levels of these Genotoxins define using HPLC-ECD with Boron-Doped Diamond 
Electrochemical Cell [11]. These methods are complicated and time-consuming when 
compared to the method proposed in the present study wherein a simple method is 
applied using HPLC technique with UV detection. 
This paper presents a simple and sensitive HPLC method using UV detector that can 
accurately quantify both MPTS and EPTS at trace levels. The method was successfully 
applied to demonstrate that these genotoxins are controlled below TTC levels in the bulk 
drug and also can be applied for the estimation of MPTS and EPTS in other drug 
substances where maximum daily dosage is up to 2 g. 
Experimental 
Chemicals 
Samples of ethyl p-toluenesulfonate and methyl p-toluenesulfonate were purchased from 
Sigma Aldrich Co., St.Louis, USA. The Drug substance, Pemetrexed disodium used for the 
study was received from Aptuit Laurus Private Limited, Hyderabad, INDIA. HPLC grade 
Acetonitrile, Methanol and AR grade Orthophosphoric acid were purchased from Merck, 
Darmstadt, Germany. High purity water was collected using Millipore Milli-Q plus water 
purification system. 
Instrumentation 
The LC systems, used in the present study are Waters Alliance equipped with a Waters 
2695 quaternary gradient pump, auto injector with 2489 UV Visible detector and 
Schimadzu LC-2010C HT equipped with quaternary gradient pump, auto injector UV 
visible detector. The output signal of both LC systems was monitored and processed 
through Empower 2 networking software; version build number 2154.  868  A. Nageswari, K. Venkata Siva Rama Krishna Reddy, and K. Mukkanti:   
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Chromatographic conditions  
The chromatographic separation was performed on a 5 µm particles, “Inertsil ODS-3V” 
(250 mm x 4.6 mm), column procured from GL science inc., Tokyo, Japan. The mobile 
phase consisted of 0.1% phosphoric acid in water and Acetonitrile in a ratio of 1:1 (v/v). 
The mobile phase was pre-mixed, filtered through a 0.45 µm nylon filter and degassed. 
The flow rate of the mobile phase was kept at 2.0 mL min
−1. The temperature of column 
was maintained at 27°C and the detection was carried out at a wavelength of 225 nm. 
Injection volume was 20 µL and run time was 15 min. Samples were prepared in Methanol. 
Preparation of solutions 
An Impurity stock solution of ethyl  p-toluenesulfonate and methyl  p-toluenesulfonate 
(0.6mg mL
−1) was prepared by dissolving appropriate amount in methanol. Test solutions 
of drug substance 60 mg mL
−1  were prepared by dissolving appropriate amount in 
methanol. 
Sample solutions of three different lots of drug substance were prepared in triplicate at a 
concentration of 60 mg mL
−1 in Methanol by dissolving appropriate amount to perform the 
analysis. 
Analytical Method Validation 
The developed chromatographic method was validated for specificity, sensitivity (limit of 
detection and limit of quantification), precision (repeatability, reproducibility and 
intermediate precision), linearity, range, accuracy and solution stability. 
Specificity 
The specificity  of the optimized method was performed by injecting stock solutions of 
individual impurities to check resolution among MPTS, EPTS, methanol and drug 
substance under the same conditions mentioned under chromatographic conditions. 
Sensitivity 
Sensitivity of the method was proven by establishing the limit of detection (LOD) and limit 
of quantitation (LOQ) for MPTS and EPTS with signal-to-noise-ratios of 3:1 and 10:1, 
respectively. LOD and LOQ were determined by injecting a series of diluted solutions 
having known concentrations of impurities. Precision of the method was also carried out at 
the LOQ level by injecting six individual preparations of MPTS and EPTS at LOQ 
concentration by calculating %RSD for the areas of each peak. 
Precision 
Precision was determined through repeatability (intra-day) and intermediate (inter-day) 
precision. Precision of the method was checked by injecting six individual preparations of 
MPTS and EPTS at 0.18 µg/mL level for each impurity with respect to concentration of the 
drug substance. %RSD for content of each impurity was calculated. 
Intermediate precision (ruggedness) of the method was evaluated by using three different 
columns, three different instruments on different days in the same laboratory at four 
different levels i.e. LOQ, 50%, 100% and 150% of the specification limit.   A Sensitive and Simple HPLC-UV Method for Trace Level Quantification of …  869 
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Tab. 1.  Intraday Precision at four levels from LOQ to 150% of specification limit in 
Day-1 
#  Concentration with respect 
to specification limit (%) 
%RSD of MPTS  
content in µg mL
−1 
%RSD of EPTS  
content in µg mL
−1 
1  LOQ  1.4  0.8 
2  50%  0.4  0.6 
3  100%  1.3  1.9 
4  150%  0.3  0.4 
n= 6 preparations. 
 
Tab. 2.  Intraday Precision at four levels from LOQ to 150% of specification limit in 
Day-2  
#  Concentration with respect 
to specification limit (%) 
%RSD of MPTS  
content in µg mL
−1 
%RSD of EPTS  
content in µg mL
−1 
1  LOQ  1.5  0.4 
2  50%  0.6  1.6 
3  100%  0.4  0.5 
4  150%  0.3  1.5 
n= 6 preparations. 
 
Tab. 3.  Intraday Precision at four levels from LOQ to 150% of specification limit in 
Day-3 
#  Concentration with respect 
to specification limit (%) 
%RSD of MPTS  
content in µg mL
−1 
%RSD of EPTS  
content in µg mL
−1 
1  LOQ  0.9  1.5 
2  50%  1.2  1.5 
3  100%  0.6  1.1 
4  150%  0.4  1.9 
n= 6 preparations. 
 
Tab. 4.  Interday Precision of three different days at four levels from LOQ to 150% of 
specification limit 
#  Concentration with respect 
to specification limit (%) 
%RSD of MPTS  
content in µg mL
−1 
%RSD of EPTS  
content in µg mL
−1 
1  LOQ  9.4  7.7 
2  50%  8.0  9.3 
3  100%  8.4  2.9 
4  150%  8.1  9.1 
n= 6 preparations. 
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Linearity and Range 
To establish the Linearity of the method, calibration solutions were prepared by diluting the 
impurity stock solution to the required concentrations at six different levels ranging from 
LOQ to 6 µg mL
−1 of each impurity. The linearity graph was drawn with concentration of 
linearity solution on x-axis and mean area counts on y-axis. The slope, y-intercept, y-bias 
and correlation coefficient of the calibration curve were calculated.  
Accuracy 
To determine accuracy of the method, a recovery study was carried out by analyzing the 
drug substance spiked with impurities. Known amount of impurities were spiked to the 
previously analyzed samples at different concentration levels of LOQ, 50%, 100% and 
150% at the specification limit of the drug substance concentration (60 mg mL
−1). Each 
concentration level was prepared in triplicate. Percentage recoveries for MPTS and EPTS 
were calculated. 
Solution stability 
Solution stability of impurities standard (0.18 µg mL
−1) was carried out by keeping them in 
tightly capped volumetric flasks at room temperature for 12 h. The solutions were analyzed 
at 1 h intervals up to 12 h.  
Results and Discussion 
LC Method optimization 
The specification limit for genotoxic impurities (MPTS and EPTS) in the selected drug 
substance has been calculated based on TTC and maximum daily dose of drug substance 
i.e. 500 mg. 
A maximum daily exposure target of Genotoxic impurities is 1.5 µg per day per person. 
Hence specification limit for impurities in ppm = 1.5 µg / Day of the drug substance in g. 
i.e. 1.5/0.5 = 3.0 ppm.  
The aim of the current study was to develop a specific and sensitive analytical method, 
which could not only separate both MPTS and EPTS from the drug substance but also 
could quantify the impurities at less than 50% to the specification limit. 
The desired specificity of the method was achieved on a 5 µm particle size, “Inertsil 
ODS-3V” (250 x 4.6 mm) column with 0.1% ortho phosphoric acid in water and Acetonitrile 
(1:1 v/v) as mobile phase. Impurities were monitored by using UV Vis detector at 225 nm. 
Flow rate was 2.0 mL
−1 and column temperature was 27 °C. Run time of the method was 
15 min. 
Analytical parameters and validation 
The developed method was validated to demonstrate that it is suitable for its intended use 
as per ICH guidelines [13, 14] (sensitivity, precision, accuracy, linearity, range, selectivity, 
and solution stability).   A Sensitive and Simple HPLC-UV Method for Trace Level Quantification of …  871 
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Sensitivity (Limit of detection and Limit of quantification) 
Sensitivity was determined by establishing limit of detection (LOD) and limit of 
quantification (LOQ) for GTIs, which were estimated through signal to-noise ratio of 3:1 
and 10:1,  respectively, by injecting a series of dilute solutions having a  known 
concentration. LOD of the impurity is defined as the lowest concentration that can be 
detected. LOD for MPTS and EPTS was found to be 0.009 µg mL
−1 (Figure 4). LOQ is the 
lowest concentration of an impurity that can be quantified with acceptable precision and 
accuracy. LOQ for MPTS and EPTS was found to be 0.03 µg mL
−1 (Figure 5). Precision 
study was also carried out at LOQ level by injecting six individual preparations of MPTS 
and EPTS by calculating the %RSD for the content in µg mL
−1 of each impurity. Results 
are shown in Table 1. 
 
Fig. 4.   LOD (0.009 µg mL
−1) chromatogram of methyl and ethyl p-toluenesulfonate  
 
 
Fig. 5.   LOQ (0.03 µg mL
−1) chromatogram of methyl and ethyl p-toluenesulfonate 872  A. Nageswari, K. Venkata Siva Rama Krishna Reddy, and K. Mukkanti:   
Sci Pharm. 2011; 79: 865–876 
Tab. 5.  Accuracy at four levels from LOQ to 150% to the specification limit in Day-1 
#  Concentration 
to 
specification 
level 
MPTS spiked to API*  EPTS spiked to API* 
X  
(µg mL
−1) 
Y  
(µg mL
−1) 
%Mean 
recovery 
±SD 
X  
(µg mL
−1) 
Y  
(µg mL
−1) 
%Mean 
recovery 
±SD 
1  LOQ  0.0307  0.0290  94.5±1.19  0.0308  0.0304    98.6±1.93 
2  50%  0.0968  0.0968  94.6±0.85  0.0896  0.0919  102.5±0.61 
3  100%  0.1839  0.1671  90.8±0.38  0.1845  0.1680    91.1±0.67 
4  150%  0.2903  0.2784  95.9±0.52  0.2687  0.2750  102.4±0.49 
n= 3 determinations; X…amount spiked; Y…amount recovered. 
 
Tab. 6.  Accuracy at four levels from LOQ to 150% in Day-2 
#  Concentration 
to 
specification 
level 
MPTS spiked to API*  EPTS spiked to API* 
X  
(µg mL
−1) 
Y  
(µg mL
−1) 
%Mean 
recovery 
±SD 
X  
(µg mL
−1) 
Y  
(µg mL
−1) 
%Mean 
recovery 
±SD 
1  LOQ  0.0305  0.0286  93.8±1.00  0.0332  0.0295    89.0±0.35 
2  50%  0.0923  0.0836  90.6±0.06  0.0947  0.0886    93.6±0.36 
3  100%  0.1826  0.1815  99.3±0.70  0.1791  0.1830  102.2±0.95 
4  150%  0.2770  0.2627  94.8±1.60  0.2840  0.2749    96.8±0.50 
n= 3 determinations; X…amount spiked; Y…amount recovered. 
 
Tab. 7.  Accuracy at four levels from LOQ to 150% in Day-3 
#  Concentration 
to 
specification 
level 
MPTS spiked to API*  EPTS spiked to API* 
X  
(µg mL
−1) 
Y  
(µg mL
−1) 
%Mean 
recovery 
±SD 
X  
(µg mL
−1) 
Y  
(µg mL
−1) 
%Mean 
recovery 
±SD 
1  LOQ  0.0307  0.0290  94.5±1.19  0.0332  0.0295    89.0±0.35 
2  50%  0.0953  0.0943  98.9±0.42  0.0893  0.0825    92.4±0.15 
3  100%  0.1839  0.1671  90.8±0.38  0.1791  0.1830  102.2±0.95 
4  150%  0.2858  0.2559  89.6±0.72  0.2680  0.2682  100.1±0.40 
n= 3 determinations; X…amount spiked; Y…amount recovered. 
 
Precision 
Precision of the method was checked by injecting six individual preparations of both MPTS 
and EPTS impurities at four different levels i.e. LOQ, 50%, 100% and 150% of the 
specification limit. %RSD was calculated for the content of MPTS and EPTS in µg mL
−1. 
Intermediate precision of the method was also evaluated using three different columns, 
three different instruments on different days, in the same laboratory. Results are 
summarized in Tables1–3. Results of inter day precision generated on three different days 
were also calculated in terms of %RSD and the results are listed in Table 4.    A Sensitive and Simple HPLC-UV Method for Trace Level Quantification of …  873 
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Linearity 
Linearity of the method was demonstrated using a six point calibration plot at 
concentrations ranging from LOQ to 100 ppm with respect to sample concentration (i.e. 
0.03, 0.18, 0.6, 1.2, 3 and 6 µg mL
−1). The correlation coefficient of linear regression is 
greater than 0.999 for each impurity.  
Accuracy 
Accuracy of the method was evaluated at four concentration levels in triplicate. Analysis 
was carried out by spiking the impurities to the drug substance at different concentrations 
of LOQ, 50%, 100% and 150% of specification limit of MPTS and EPTS (i.e. 0.03, 0.09, 
0.18 and 0.27 µg mL
−1). The % recoveries were calculated for both GTIs which were found 
to be 90 to 99 % and 89 to 103% for MPTS and EPTS, respectively. Typical overlaid 
chromatogram of drug substance and drug substance spiked with impurities is shown in 
Figure 6. Results of accuracy study are summarized in Tables 5–7. 
 
Fig. 6.   Chromatogram of Accuracy at 100% specification level (0.18 µg mL
−1)  
Specificity 
Selectivity of the method for the estimation of MPTS and EPTS in drug substance 
described in the present study was proven by injecting separately solutions of drug 
substance, other related impurities that are expected to be present in the drug substance 
and the two Genotoxins where drug substance and its related impurities eluted below 
4 minutes and GTIs eluted after 5 min (Figure 7). 874  A. Nageswari, K. Venkata Siva Rama Krishna Reddy, and K. Mukkanti:   
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Fig. 7.   Overlaid chromatogram of different lots of drug substance with standard 
solution of 0.18 µg mL
−1 of MPTS and EPTS impurities 
Solution stability 
Solution stability of impurities was studied up to 12 h at room temperature and found no 
significant difference in the area of impurities was observed from initial to 12 h period. P 
value calculated using student’s t-test was 0.10 (10%) [15]. The similarity factors for both 
MPTS and EPTS in solution stability experiments were 1.00 and 1.03, respectively. 
Batch analysis 
Three different lots of Pemetrexed disodium drug substance were analyzed in triplicate in 
the validated method for estimation of MPTS and EPTS and found that both the impurities 
were below Detection Limit (< 0.009 µg mL
−1).  
Conclusion 
The present study describes a sensitive, simple, rapid and accurate validated LC method 
by using UV detection for estimation of potential GTIs, MPTS and EPTS in the drug 
substance. The method was found to be selective, sensitive, precise, accurate and linear 
for the determination of GTIs. This method is suitable for quantification of MPTS and EPTS 
in any other drug substances with a maximum daily dose up to 2.0 g.  
   A Sensitive and Simple HPLC-UV Method for Trace Level Quantification of …  875 
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